Cargando…
Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers
Gastric cancer (GC) is a deadly disease with limited treatment options. Recent studies with PD-1 inhibition have shown promising results in GC, but key questions remain regarding which GC subclass may respond best. In other cancers, expression of the PD-1 ligand PD-L1 has been shown to identify canc...
Autores principales: | Derks, Sarah, Liao, Xiaoyun, Chiaravalli, Anna M., Xu, Xinsen, Camargo, M. Constanza, Solcia, Enrico, Sessa, Fausto, Fleitas, Tania, Freeman, Gordon J., Rodig, Scott J., Rabkin, Charles S., Bass, Adam J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078063/ https://www.ncbi.nlm.nih.gov/pubmed/27147580 http://dx.doi.org/10.18632/oncotarget.9076 |
Ejemplares similares
-
Associations of Epstein-Barr Virus-Positive Gastric Adenocarcinoma with Circulating Mediators of Inflammation and Immune Response
por: Camargo, M. Constanza, et al.
Publicado: (2018) -
Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis
por: Camargo, M C, et al.
Publicado: (2011) -
Antibodies Against Epstein–Barr Virus as Disease Markers of Gastric Cancer: A Systematic Review
por: Fontes-Lemus, José I., et al.
Publicado: (2023) -
Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009) -
The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)